5 research outputs found
ΠΠΊΠΎΠ½ΠΎΠΌΠΈΡΠ΅ΡΠΊΠΈΠΉ ΠΌΠ΅Ρ Π°Π½ΠΈΠ·ΠΌ ΠΏΡΠΈΠ²Π»Π΅ΡΠ΅Π½ΠΈΡ ΠΈΠ½Π²Π΅ΡΡΠΈΡΠΈΠΉ Π² Π³ΠΎΡΠ½ΠΎ-ΠΌΠ΅ΡΠ°Π»Π»ΡΡΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΎΡΡΠ°ΡΠ»ΠΈ (Π½Π° ΠΏΡΠΈΠΌΠ΅ΡΠ΅ ΠΠ Β«ΠΠ»ΠΌΠ°Π»ΡΠΊΡΠΊΠΈΠΉ Π³ΠΎΡΠ½ΠΎ-ΠΌΠ΅ΡΠ°Π»Π»ΡΡΠ³ΠΈΡΠ΅ΡΠΊΠΈΠΉ ΠΊΠΎΠΌΠ±ΠΈΠ½Π°ΡΒ»)
ΠΠ±ΡΠ΅ΠΊΡ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ β Π°ΠΊΡΠΈΠΎΠ½Π΅ΡΠ½ΠΎΠ΅ ΠΎΠ±ΡΠ΅ΡΡΠ²ΠΎ "ΠΠΠΠ".
Π¦Π΅Π»Ρ: ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ ΡΠΊΠΎΠ½ΠΎΠΌΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΌΠ΅Ρ
Π°Π½ΠΈΠ·ΠΌΠ° ΠΏΡΠΈΠ²Π»Π΅ΡΠ΅Π½ΠΈΡ ΠΈΠ½Π²Π΅ΡΡΠΈΡΠΈΠΉ Π² Π³ΠΎΡΠ½ΠΎβΠΌΠ΅ΡΠ°Π»Π»ΡΡΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΎΡΡΠ°ΡΠ»ΠΈ.
ΠΠΊΡΡΠ°Π»ΡΠ½ΠΎΡΡΡ: ΠΏΡΠΎΠ±Π»Π΅ΠΌΠ° ΠΌΠΎΠ±ΠΈΠ»ΠΈΠ·Π°ΡΠΈΠΈ ΠΈΠ½Π²Π΅ΡΡΠΈΡΠΈΠΉ Π² ΠΏΡΠΎΠΌΡΡΠ»Π΅Π½Π½ΡΠ΅ ΠΊΠΎΠΌΠΏΠ°Π½ΠΈΠΈ.
ΠΠ°Π΄Π°ΡΠΈ ΡΠ°Π±ΠΎΡΡ:
1. Π²ΡΡΠ²ΠΈΡΡ ΡΠΎΠ»Ρ ΠΈΠ½Π²Π΅ΡΡΠΈΡΠΈΠΉ Π² ΡΠΈΡΡΠ΅ΠΌΠ΅ Π³ΠΎΡΡΠ΄Π°ΡΡΡΠ²Π΅Π½Π½ΡΡ
ΠΏΡΠΈΠΎΡΠΈΡΠ΅ΡΠΎΠ² ΡΠ°Π·Π²ΠΈΡΠΈΡ ΡΠΊΠΎΠ½ΠΎΠΌΠΈΠΊΠΈ Π Π£Π·;
2. ΠΈΠ·ΡΡΠΈΡΡ ΠΎΡΠ½ΠΎΠ²Π½ΡΠ΅ ΠΈΠ½ΡΡΡΡΠΌΠ΅Π½ΡΡ Π΄Π»Ρ ΠΏΡΠΈΠ²Π»Π΅ΡΠ΅Π½ΠΈΡ ΠΈΠ½Π²Π΅ΡΡΠΈΡΠΈΠΉ Π Π£Π·;
3. ΠΏΡΠΎΠ²Π΅ΡΡΠΈ Π°Π½Π°Π»ΠΈΠ· ΠΈΠ½Π²Π΅ΡΡΠΈΡΠΈΠΎΠ½Π½ΠΎΠΉ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ ΠΠ "ΠΠΠΠ".The object of research is the joint-stock company "AGMK".
Purpose: study of the economic mechanism of attracting investments in the mining and metallurgical industry.
Relevance: the problem of mobilizing investments in industrial companies.
Tasks of work:
1. to identify the role of investments in the system of state priorities for the development of the economy of the Republic of Uzbekistan;
2. To study the basic tools for attracting investment of the Republic of Uzbekistan
3. to analyze the investment activity of AGMK JSC
Dual role of macrophage migration inhibitory factor (MIF) in human breast cancer
Abstract Background Macrophage migration inhibitory factor (MIF) is a pleiotropic cytokine and mediator of acute and chronic inflammatory diseases. MIF is overexpressed in various tumours and has been suggested as a molecular link between chronic inflammation and cancer. MIF overexpression is observed in breast cancer but its causal role in the development of this tumour entity is unclear. Methods MIF levels in breast cancer cell lines were determined by ELISA and Western blot. CD74 was measured by Western blot, fluorescence microscopy and flow cytometry. Cell proliferation was studied by BrdU incorporation, cell adhesion by Matrigel adhesion assay, and cell invasion by migration assay through Matrigel-coated filters using the Transwell system. MIF expression in primary human breast cancers was measured by tissue microarray and a semi-quantitative immunoreactivity score (IRS) and comparison with histopathological parameters and patient outcome data. Results MIF was abundantly expressed in the non-invasive breast cancer cell lines MDA-MB-468 and ZR-75-1, but not in invasive MDA-MB-231 cells, which in turn expressed higher levels of the MIF-receptor CD74. Stimulation with exogenous MIF led to a dramatic upregulation of MIF secretion (50-fold) in MDA-MB-231 cells. Autocrine MIF promoted tumour cell proliferation, as indicated by blockade of MIF or CD74 in MDA-MB-231 and MDA-MB-468, and MDA-MB-231 invasiveness was enhanced by exogenous MIF. We correlated the expression of MIF with histopathological parameters and patient outcome data, using a tissue microarray of 175 primary invasive breast cancers and 35 normal control tissues. MIF was upregulated in breast cancer versus normal tissue (median IRS = 8 versus 6). MIF expression showed positive correlations with progesterone (p = 0.006) and estrogen (p = 0.028) receptor expression, markers of a favourable prognosis and a negative correlation to tumour size (p = 0.007). In line with these data, disease-specific overall (OS) as well as recurrence-free (RFS) survival was significantly improved in breast cancer patients with abundant cytosolic MIF expression compared to MIF low expressers (5-year OS = 67% versus 50%, p = 0.0019; 5-year RFS = 52% versus 36%, p = 0.0327). Conclusion We conclude that intracellular expression of MIF in breast cancer cells is beneficial, whereas extracellular MIF may play a pro-oncogenic role in promoting breast cancer cell-stroma interactions.</p
The nucleoporin Nup50 activates the Ran guanine nucleotide exchange factor RCC1 to promote NPC assembly at the end of mitosis
During mitotic exit, thousands of nuclear pore complexes (NPCs) assemble concomitant with the nuclear envelope to build a transport-competent nucleus. Here, we show that Nup50 plays a crucial role in NPC assembly independent of its well-established function in nuclear transport. RNAi-mediated downregulation in cells or immunodepletion of Nup50 protein in Xenopus egg extracts interferes with NPC assembly. We define a conserved central region of 46 residues in Nup50 that is crucial for Nup153 and MEL28/ELYS binding, and for NPC interaction. Surprisingly, neither NPC interaction nor binding of Nup50 to importin alpha/beta, the GTPase Ran, or chromatin is crucial for its function in the assembly process. Instead, an N-terminal fragment of Nup50 can stimulate the Ran GTPase guanine nucleotide exchange factor RCC1 and NPC assembly, indicating that Nup50 acts via the Ran system in NPC reformation at the end of mitosis. In support of this conclusion, Nup50 mutants defective in RCC1 binding and stimulation cannot replace the wild-type protein in in vitro NPC assembly assays, whereas excess RCC1 can compensate the loss of Nup50.ISSN:0261-4189ISSN:1460-207